Ovid Therapeutics (OVID)

• Market cap: $111M
• 1 day: -2.5%
• 5 days: 4%
• 1 month: -6.59%
• 3 months: 15.56%
• 6 months: 180.73%
• Year to date: -11.36%
• 1 year: 142.99%
• 5 years: -55.43%
• 10 years: -87.27%
• Sector: Healthcare
• Industry: Biotechnology

About: Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Employees: 23